基本信息
浏览量:269
职业迁徙
个人简介
Dr. Nagy has made significant breakthroughs in developmental genetics, mouse and human pluripotent stem cell biology (both embryonic and reprogramming-induced), disease modelling and cell therapy approaches. His team created the first Canadian human embryonic stem cell lines in early 2000. In 2009, they developed the first method allowing the generation of iPS cell lines without any genetic change. Their approach allowed studying the reprogramming process at multiple OMICS levels, almost at daily resolution from differentiated cells to pluripotency. His current research has become even more translational by addressing and coming up with solutions for two significant hurdles of cell therapies: safety and allogeneic cell acceptance without the need for suppression of the immune system. His research has been aiming to advance medicine with a focus to treat incurable degenerative diseases, such as blindness, diabetes, arthritis, spinal cord injury, multiple sclerosis, haemophilia, and hypoparathyroidism.
研究兴趣
论文共 743 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
NEUROLOGYno. 17 (2023)
引用0浏览0引用
0
0
Evan Sawula,Shane Miersch, Eric D. Jong,Chengjin Li, Fang-Yu Chou,Jean Kit Tang,Reza Saberianfar,Jeffrey Harding,Sachdev S. Sidhu,Andras Nagy
Stem cell research & therapyno. 1 (2023): 1-15
ADVANCED FUNCTIONAL MATERIALSno. 43 (2023)
ZOOKEYSno. 1166 (2023): 351-373
Mohammad Izadifar,Tunde Berecz, Biao Li, Jean Kitty Kit Yee Tang,Gabor Foldes,Agota Apati,Andras Nagy
Current protocolsno. 9 (2023)
Journal of Clinical Immunologyno. 1 (2023): 28-28
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn